ReiThera Completes Enrolment of Subjects in the Phase 2 Part of the Phase 2/3 Clinical Trial of its GRAd-COV2 Vaccine Candidate against COVID-19
ROME, Italy, April 26th, 2021 – ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and medicinal [...]